Suppr超能文献

尿激酶原:其在血浆中的稳定性及选择性纤溶作用机制的研究

Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.

作者信息

Pannell R, Gurewich V

出版信息

Blood. 1986 May;67(5):1215-23.

PMID:3083889
Abstract

Highly purified pro-urokinase (pro-UK) or single-chain urokinase-type plasminogen activator (scu-PA) was treated with diisopropylfluorophosphate (1 mmol/L) to eliminate traces of two-chain UK activity. This preparation was found to retain a low activity against a chromogenic substrate (S2444), equivalent to 0.1% to 0.5% of the activity of its plasmin-activated derivative. Evidence is presented that the intrinsic activity of pro-UK (scu-PA) was sufficient to activate plasminogen on a fibrin plate or in buffer and was far more reactive against Lys-plasminogen than against Glu-plasminogen. The relative resistance of Glu-plasminogen to activation was overcome by the addition of lysine (25 mmol/L) to the reaction mixture. By contrast, in plasma, pro-UK (scu-PA) was stable and nonreactive for greater than 72 hours when incubated (37 degrees C). Pro-UK (scu-PA) did not form sodium dodecyl sulfate-stable inhibitor complexes, whereas complexation occurred rapidly with UK. Only at high concentrations of pro-UK (scu-PA) (greater than or equal to 250 IU/mL) did plasminogen activation in plasma occur. The relative inertness of pro-UK (scu-PA) in plasma, in contrast to its low-grade enzymatic activity in buffer, was attributed to the effect of inhibitors. The addition of EDTA or the removal of divalent cations by dialysis was associated with a lower threshold for nonspecific plasminogen activation by pro-UK (scu-PA) in plasma. Replacement of Ca++ but not other cations restored baseline conditions. In the presence of a clot, fibrin-selective plasminogen activation and clot lysis were triggered. Lysis was accompanied by less than 10% conversion of pro-UK (scu-PA) to two-chain UK, suggesting that the intrinsic activity of pro-UK (scu-PA) itself may have been responsible for fibrinolysis, although a contribution by the small amount of UK generated could not be excluded. Similarly, pro-UK (scu-PA) supported clot lysis for several days in the same plasma before the effect dissipated as a result of degradation to UK. When Glu-plasminogen in plasma was replaced by Lys-plasminogen, or when lysine was added to normal plasma, nonselective plasminogen activation and fibrinogenolysis occurred. It was concluded that under the experimental conditions, the fibrin specificity of pro-UK (scu-PA) can be explained by its selective activation of fibrin-bound plasminogen and is due to the latter's Lys-plasminogen-like conformation.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

用二异丙基氟磷酸(1毫摩尔/升)处理高度纯化的尿激酶原(pro-UK)或单链尿激酶型纤溶酶原激活剂(scu-PA),以消除痕量的双链尿激酶活性。发现该制剂对显色底物(S2444)仍保留低活性,相当于其纤溶酶激活衍生物活性的0.1%至0.5%。有证据表明,尿激酶原(scu-PA)的内在活性足以在纤维蛋白平板上或缓冲液中激活纤溶酶原,并且对赖氨酸纤溶酶原的反应性远高于对谷氨酸纤溶酶原的反应性。通过向反应混合物中添加赖氨酸(25毫摩尔/升),克服了谷氨酸纤溶酶原对激活的相对抗性。相比之下,在血浆中,尿激酶原(scu-PA)在37℃孵育时稳定且72小时以上无反应性。尿激酶原(scu-PA)不形成十二烷基硫酸钠稳定的抑制剂复合物,而与尿激酶迅速形成复合物。仅在高浓度的尿激酶原(scu-PA)(大于或等于250国际单位/毫升)时,血浆中的纤溶酶原激活才会发生。与尿激酶原(scu-PA)在缓冲液中的低水平酶活性相比,其在血浆中的相对惰性归因于抑制剂的作用。添加乙二胺四乙酸(EDTA)或通过透析去除二价阳离子与血浆中尿激酶原(scu-PA)非特异性激活纤溶酶原的较低阈值相关。用钙离子替代但不是其他阳离子可恢复基线条件。在有凝块的情况下,触发了纤维蛋白选择性纤溶酶原激活和凝块溶解。溶解伴随着尿激酶原(scu-PA)向双链尿激酶的转化不到10%,这表明尿激酶原(scu-PA)本身的内在活性可能是纤维蛋白溶解的原因,尽管不能排除少量生成的尿激酶的作用。同样,尿激酶原(scu-PA)在同一血浆中支持凝块溶解数天,直到由于降解为尿激酶而效果消失。当血浆中的谷氨酸纤溶酶原被赖氨酸纤溶酶原替代,或向正常血浆中添加赖氨酸时,发生非选择性纤溶酶原激活和纤维蛋白原溶解。得出的结论是,在实验条件下,尿激酶原(scu-PA)的纤维蛋白特异性可通过其对纤维蛋白结合的纤溶酶原的选择性激活来解释,并且是由于后者的赖氨酸纤溶酶原样构象。(摘要截短至400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验